Rapid Progression of Low-Grade Cervical Dysplasia into Invasive Cancer during Natalizumab Treatment for Relapsing Remitting Multiple Sclerosis

A 25-year-old patient treated for relapsing remitting multiple sclerosis (RRMS) with natalizumab had a rapid progression of a low grade squamous intraepithelial lesion to a FIGO stage 1B1 squamous cell carcinoma of the uterine cervix within 2 years. She was treated with radical hysterectomy and pelv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, King Man, Oehler, Martin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477472/
https://www.ncbi.nlm.nih.gov/pubmed/31043942
http://dx.doi.org/10.1159/000496198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477472/
https://www.ncbi.nlm.nih.gov/pubmed/31043942
http://dx.doi.org/10.1159/000496198

Ejemplares similares